Insulin Resistance

Insulin resistance can improve with structured exercise and diet-driven weight loss. A clinical trial in adults with metabolic-syndrome traits showed that weight loss from diet and exercise improved insulin sensitivity and lowered markers of oxidative stress (Rector et al., 2007). You can start by reviewing your daily activity and nutrition with your physician to establish a sustainable caloric deficit.

Insulin resistance and type 2 diabetes sit on the same metabolic spectrum, but they represent different stages. With insulin resistance, your body produces higher amounts of insulin to keep blood glucose in range, while prediabetes marks the intermediate stage. Type 2 diabetes occurs when the pancreas can no longer produce enough insulin to compensate, leaving blood sugar persistently high. Periodic lab testing helps your physician identify these shifts and intervene before glucose levels rise further.

Physicians commonly evaluate insulin resistance by ordering a fasting insulin test alongside a fasting glucose test. Evaluating these markers together generates a homeostatic model assessment of insulin resistance (HOMA-IR), which can flag metabolic dysfunction before standard blood sugar readings become abnormal. You can ask your doctor to check both markers at your next routine blood draw.

The relationship runs in both directions. Excess visceral fat drives insulin resistance, while insulin resistance impairs normal appetite regulation and fat storage, which can lead to additional weight gain. Breaking this cycle requires reducing visceral fat through consistent resistance exercise, dietary changes, or a clinician-guided program to lose weight.

Insulin resistance and high blood pressure are linked through several proposed mechanisms, though the exact causal direction remains debated in clinical research. Elevated insulin promotes sodium retention by the kidneys to increase blood volume, can stimulate the sympathetic nervous system, and may alter blood vessel tone. A mechanistic review describes this relationship as an association involving multiple shared pathways rather than a settled single cause. Your physician can evaluate both markers together to assess your cardiovascular risk.

Insulin resistance does not appear as its own line item on a standard lipid panel, but it frequently correlates with a distinct blood lipid pattern. Specifically, a higher ratio of triglycerides to HDL cholesterol is associated with reduced insulin sensitivity. Research examining the triglyceride-to-HDL ratio has used a value around 3 or higher as an indicator of insulin resistance, though diagnostic cutoffs vary across study populations. A physician evaluates this ratio alongside your fasting glucose and insulin rather than relying on a single cutoff.

Acanthosis nigricans is a recognized visible skin marker associated with insulin resistance. It appears as dark, thickened, velvety patches of skin, most commonly around the neck, armpits, or groin. Seeing these skin changes does not confirm a diagnosis on its own, but it is an outward physical sign to discuss with your physician. A proper medical evaluation pairs a physical exam with targeted blood tests to measure your metabolic markers directly.

Research into brain insulin resistance focuses on cognitive decline and neurodegenerative risk rather than daily tiredness. A 2024 review notes that impaired brain glucose metabolism can occur in the aging brain, even in people without diabetes, and is investigated in conditions such as Alzheimer's disease. Daily fatigue has many potential causes, including sleep disruption, thyroid issues, and hormone imbalances. If low energy is your primary concern, a comprehensive physician workup identifies the underlying factors instead of attributing fatigue to a single metabolic marker.